Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

BUSINESS COMBINATIONS - Disclosure of detailed information about proforma acquisition (Details)

v3.23.1
BUSINESS COMBINATIONS - Disclosure of detailed information about proforma acquisition (Details) - Pro Forma [Member]
$ in Thousands
 12 Months Ended
Dec. 31, 2021
CAD ($)
Trichome Financial Corp. (“Trichome”) [Member]  
Disclosure of detailed information about business combination [line items]  
Net revenues $ 55,563
Net loss (25,372)
MYM Nutraceuticals Inc. (“MYM”) [Member]  
Disclosure of detailed information about business combination [line items]  
Net revenues 61,639
Net loss (20,132)
Vironna pharmacy [Member]  
Disclosure of detailed information about business combination [line items]  
Net revenues 56,816
Net loss (18,180)
Pharm Yarok pharmacy [Member]  
Disclosure of detailed information about business combination [line items]  
Net revenues 58,345
Net loss (18,986)
Oranim pharmacy [Member]  
Disclosure of detailed information about business combination [line items]  
Net revenues 67,589
Net loss $ (17,870)